Caplin Point Laboratories Peer Comparison

Caplin Point Laboratories Ltd. displays strong growth and profitability metrics compared to its peers, with the highest revenue growth rates and solid margins, positioning it as a sector leader in the pharmaceuticals and drugs industry. However, it also has a high valuation, which may temper its attractiveness for value-seeking investors.

• • Caplin Point has the highest revenue growth (YoY: 15.5%, 3-Year: 15.14%) among peers.
• • Dr. Reddy's Laboratories boasts the highest ROE and ROCE at 21.76% and 26.86%, respectively.
• • Cipla Ltd. has the lowest PE ratio at 23.73, making it an attractive value pick.
• • Divi's Laboratories has the lowest revenue growth YoY at 1% and a declining EPS over 3 years.

• • Caplin Point Laboratories Ltd.: Highest revenue growth rates and strong profitability metrics.
• • Dr. Reddy's Laboratories Ltd.: Strong ROE and ROCE, indicating effective use of equity and capital.
• • Cipla Ltd.: Lowest PE ratio, suggesting it may be undervalued relative to earnings.